Androski Lindsay bought ABUS
February 2, 2026 · Form 4 insider transaction
Androski Lindsay bought 71,700 shares of Arbutus Biopharma Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
71,700
Price
$0.00
Total value
N/A
InsiderAndroski Lindsay
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 2, 2026
Filing dateFebruary 2, 2026
Shares owned after71,700
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.; This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date.